Sibila, Oriol <br/><br/>
Antimicrobial peptides, disease severity and exacerbations in bronchiectasis.  [electronic resource] 

 -  Thorax  09 2019 
 - 835-842 p.  digital 
<br/><br/> Publication Type: Journal Article; Multicenter Study; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1468-3296 
<br/><br/><label>Standard No.: </label>10.1136/thoraxjnl-2018-212895  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Aged<br/>Antimicrobial Cationic Peptides--immunology<br/>Biomarkers--metabolism<br/>Bronchiectasis--immunology<br/>Disease Progression<br/>Europe<br/>Female<br/>Humans<br/>Lactoferrin--immunology<br/>Male<br/>Muramidase--immunology<br/>Phenotype<br/>Prospective Studies<br/>Secretory Leukocyte Peptidase Inhibitor--immunology<br/>Severity of Illness Index<br/>Sputum--metabolism<br/>Cathelicidins